Rationale and design of the BAYES (Interatrial Block and Yearly Events) registry

The prevalence of interatrial block ( IAB ) is high in the elderly, particularly in those with heart disease. Despite this high prevalence—and the association of IAB with the risk of atrial fibrillation ( AF ), stroke, and cognitive decline—little information exists about the prognosis of older patients with IAB . P‐wave duration and morphology are associated with risk of developing AF , stroke, and cognitive decline in elderly patients with structural heart disease. The aim of the Interatrial Block and Yearly Events ( BAYES ) registry is to assess the impact of IAB on the risk of AF and stroke during 3 years of follow‐up. A series of 654 ambulatory patients age ≥70 years with heart disease from 35 centers will be included in 3 similar‐size groups of patients. Group A: normal P‐wave duration (<120 ms); Group B: partial IAB (P‐wave duration ≥120 ms without biphasic [plus/minus] morphology in the inferior leads II , III , and aVF ); and Group C: advanced IAB (P‐wave duration ≥120 ms with biphasic [plus/minus] morphology in the inferior leads II , III , and aVF ). Patients will be managed according to current recommendations. The 2 primary endpoints are defined as (1) AF duration >5 minutes and documented in any form of electrocardiographic recording; and (2) stroke. Results from this study might significantly improve the knowledge of IAB and its impact on the outcome of elderly patients with heart disease and could open the door to the use of anticoagulation therapy in some elderly patients with IAB .